Foundation Resource Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Buy |
936,078
+3,593
| +0.4% | +$94K | 2.62% | 13 |
|
|
2026
Q1 | $26.2M | Buy |
932,485
+31,939
| +4% | +$850K | 2.95% | 10 |
|
|
2025
Q4 | $22.4M | Sell |
900,546
-3,095
| -0.3% | -$78K | 3% | 11 |
|
|
2025
Q3 | $23M | Buy |
903,641
+10,867
| +1% | +$268K | 3.31% | 10 |
|
|
2025
Q2 | $21.6M | Buy |
892,774
+649
| +0.1% | +$15.1K | 3.35% | 11 |
|
|
2025
Q1 | $22.6M | Buy |
892,125
+323,118
| +57% | +$8.46M | 3.56% | 11 |
|
|
2024
Q4 | $15.1M | Sell |
569,007
-5,216
| -0.9% | -$141K | 2.52% | 13 |
|
|
2024
Q3 | $16.6M | Sell |
574,223
-1,449
| -0.3% | -$42.3K | 2.57% | 13 |
|
|
2024
Q2 | $16.1M | Buy |
575,672
+1,373
| +0.2% | +$37.8K | 2.57% | 12 |
|
|
2024
Q1 | $15.9M | Buy |
574,299
+5,272
| +0.9% | +$146K | 2.5% | 14 |
|
|
2023
Q4 | $16.4M | Buy |
569,027
+98,580
| +21% | +$2.98M | 2.61% | 14 |
|
|
2023
Q3 | $15.6M | Sell |
470,447
-2,313
| -0.5% | -$81.8K | 2.59% | 12 |
|
|
2023
Q2 | $17.3M | Buy |
472,760
+73,643
| +18% | +$2.87M | 2.89% | 12 |
|
|
2023
Q1 | $16.3M | Buy |
399,117
+1,521
| +0.4% | +$65.7K | 2.7% | 14 |
|
|
2022
Q4 | $20.4M | Sell |
397,596
-754
| -0.2% | -$36.1K | 3.37% | 9 |
|
|
2022
Q3 | $17.4M | Buy |
398,350
+3,421
| +0.9% | +$166K | 3.31% | 11 |
|
|
2022
Q2 | $20.7M | Sell |
394,929
-1,337
| -0.3% | -$68.1K | 3.69% | 9 |
|
|
2022
Q1 | $20.5M | Sell |
396,266
-4,280
| -1% | -$222K | 3.17% | 11 |
|
|
2021
Q4 | $23.7M | Sell |
400,546
-6,150
| -2% | -$305K | 4.6% | 8 |
|
|
2021
Q3 | $17.5M | Sell |
406,696
-1,414
| -0.3% | -$62.6K | 3.95% | 10 |
|
|
2021
Q2 | $16M | Sell |
408,110
-8,885
| -2% | -$346K | 3.59% | 10 |
|
|
2021
Q1 | $15.1M | Buy |
416,995
+30,584
| +8% | +$1.09M | 3.6% | 11 |
|
|
2020
Q4 | $14.2M | Sell |
386,411
-23,754
| -6% | -$871K | 3.71% | 11 |
|
|
2020
Q3 | $14.3M | Sell |
410,165
-12,033
| -3% | -$422K | 4.36% | 8 |
|
|
2020
Q2 | $13.1M | Sell |
422,198
-11,616
| -3% | -$395K | 4.03% | 9 |
|
|
2020
Q1 | $13.4M | Sell |
433,814
-96,051
| -18% | -$3.27M | 4.79% | 5 |
|
|
2019
Q4 | $19.7M | Sell |
529,865
-5,877
| -1% | -$209K | 4.46% | 7 |
|
|
2019
Q3 | $18.3M | Sell |
535,742
-7,595
| -1% | -$276K | 3.99% | 9 |
|
|
2019
Q2 | $22.3M | Sell |
543,337
-3,312
| -0.6% | -$132K | 4.56% | 8 |
|
|
2019
Q1 | $22M | Sell |
546,649
-21,033
| -4% | -$842K | 4.62% | 10 |
|
|
2018
Q4 | $23.5M | Sell |
567,682
-338
| -0.1% | -$14K | 5.08% | 7 |
|
|
2018
Q3 | $23.8M | Sell |
568,020
-222,312
| -28% | -$8.56M | 4.59% | 9 |
|
|
2018
Q2 | $27.2M | Sell |
790,332
-4,732
| -0.6% | -$162K | 5.27% | 6 |
|
|
2018
Q1 | $26.8M | Sell |
795,064
-529,147
| -40% | -$18.2M | 5.38% | 5 |
|
|
2017
Q4 | $45.5M | Sell |
1,324,211
-190,248
| -13% | -$6.49M | 8.19% | 2 |
|
|
2017
Q3 | $51.3M | Sell |
1,514,459
-22,358
| -1% | -$719K | 8.5% | 1 |
|
|
2017
Q2 | $49M | Sell |
1,536,817
-2,942
| -0.2% | -$92.8K | 8.78% | 1 |
|
|
2017
Q1 | $50M | Sell |
1,539,759
-102,203
| -6% | -$3.22M | 8.76% | 1 |
|
|
2016
Q4 | $50.6M | Sell |
1,641,962
-7,092
| -0.4% | -$217K | 8.56% | 1 |
|
|
2016
Q3 | $53M | Sell |
1,649,054
-8,520
| -0.5% | -$285K | 9.46% | 1 |
|
|
2016
Q2 | $55.4M | Sell |
1,657,574
-1,713
| -0.1% | -$54.7K | 10.31% | 1 |
|
|
2016
Q1 | $46.7M | Sell |
1,659,287
-18,366
| -1% | -$525K | 9.59% | 1 |
|
|
2015
Q4 | $51.4M | Sell |
1,677,653
-26,861
| -2% | -$845K | 11.14% | 1 |
|
|
2015
Q3 | $50.8M | Sell |
1,704,514
-12,226
| -0.7% | -$392K | 10.92% | 1 |
|
|
2015
Q2 | $54.6M | Sell |
1,716,740
-63,919
| -4% | -$2.08M | 9.89% | 1 |
|
|
2015
Q1 | $58.8M | Sell |
1,780,659
-184,248
| -9% | -$5.86M | 9.66% | 1 |
|
|
2014
Q4 | $58.1M | Sell |
1,964,907
-5,652
| -0.3% | -$162K | 8.16% | 1 |
|
|
2014
Q3 | $55.3M | Sell |
1,970,559
-45,171
| -2% | -$1.27M | 7.22% | 1 |
|
|
2014
Q2 | $56.8M | Sell |
2,015,730
-16,463
| -0.8% | -$469K | 6.93% | 2 |
|
|
2014
Q1 | $61.9M | Sell |
2,032,193
-90,644
| -4% | -$2.7M | 7.91% | 1 |
|
|
2013
Q4 | $61.7M | Sell |
2,122,837
-9,227
| -0.4% | -$269K | 7.76% | 1 |
|
|
2013
Q3 | $58.1M | Sell |
2,132,064
-11,301
| -0.5% | -$307K | 7.46% | 1 |
|
|
2013
Q2 | $57M | Buy |
+2,143,365
| New | +$59.2M | 7.43% | 1 |
|
Other funds holding PFE
Foundation Resource Management's PFE Position: Q2 2026 in Review
Foundation Resource Management increased its Pfizer (PFE) stake by 0.39% in Q2 2026, buying an estimated $94K and bringing the position to 936,078 shares worth $22.5M. The position accounts for 2.62% of the portfolio, ranked #13.
Foundation Resource Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $61.9M in Q1 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Foundation Resource Management held 936,078 shares of Pfizer worth $22.5M as of Q2 2026.
- Foundation Resource Management bought 3,593 Pfizer shares in Q2 2026, an estimated $94K.
- Pfizer made up 2.62% of Foundation Resource Management's portfolio in Q2 2026, its #13 holding.
- Foundation Resource Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Foundation Resource Management's Pfizer position peaked at $61.9M in Q1 2014.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Foundation Resource Management's 13F filing for Q2 2026, filed 21 Jul 2026.